NMN (Nicotinamide Mononucleotide) for Foundational Health
TL;DR
NMN is a direct precursor to NAD+, a molecule required for cellular energy production, DNA repair and hundreds of enzymatic reactions. Human trials consistently show that oral NMN raises blood NAD+ levels and is generally well tolerated. It is best viewed as foundational cellular energy support rather than a targeted therapeutic. Evidence rating: ⭐⭐⭐⭐ Strong for NAD+ elevation; ⭐⭐⭐ Promising for broader cellular support.
Evidence Rating: ⭐⭐⭐⭐ Strong for raising NAD+; ⭐⭐⭐ Promising as foundational cellular energy support
What the Research Shows for Foundational Health
NAD+ is essential for mitochondrial ATP production and the activity of sirtuins and PARPs — enzymes involved in cellular maintenance. Levels of NAD+ decline with age and metabolic stress. Multiple randomised controlled trials confirm that supplemental NMN increases circulating NAD+ and related metabolites in a dose-dependent manner. This reliable biomarker effect underpins its use as a foundational nutrient for cellular energy status.
Key Benefits
- Consistently elevates blood NAD+ levels across human trials
- Supports the cellular energy systems that decline with age
- Generally well tolerated at doses used in clinical studies
- Provides a direct substrate for NAD+ biosynthesis
- May complement other foundational practices (sleep, exercise, nutrition)
Key Studies
- Yoshino M. et al. (2021) — Demonstrated metabolic effects alongside NAD+ pathway engagement. Science. DOI: 10.1126/science.abe9985
- Igarashi M. et al. (2022) — Clear NAD+ elevation in healthy older men with 250 mg/day. npj Aging. DOI: 10.1038/s41514-022-00084-z
- Yi L. et al. (2023) — Dose-dependent increase in blood NAD+ (300–900 mg). GeroScience. DOI: 10.1007/s11357-022-00705-1
- Pencina K.M. et al. (2023) — Significant NAD+ rise plus secondary cardiometabolic markers. J Clin Endocrinol Metab. DOI: 10.1210/clinem/dgad027
Expert Views
Dr. David Sinclair has highlighted the central role of NAD+ in ageing biology and the potential of precursors such as NMN.
Dr. Peter Attia and Dr. Rhonda Patrick both discuss NAD+ metabolism as a foundational area of interest for cellular health and healthspan, while noting that human outcome data continue to mature.
NZ Context
Foundational cellular support is relevant across the adult lifespan. For New Zealanders interested in maintaining energy and metabolic resilience, NMN is one evidence-based option within a broader lifestyle framework.
Recommended Dosage
- Typical effective range for NAD+ elevation: 250–600 mg per day
- Higher doses (up to 900 mg) used in some trials
- Morning dosing is common
- Consistency is more important than exact timing
Safety Notes
Short-to-medium-term trials report good tolerability. Long-term data are still limited. Consult a healthcare professional before use if you have any medical conditions or take medications.
This is not medical advice. BioHackNZ provides general information based on published research. NMN is a complementary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement regimen. Individual results vary.
Last updated: 22 August 2026 | BioHackNZ Research Team
Shop Nicotinamide Mononucleotide (NMN)
View Product →